The health care and pharma industries are particularly vulnerable to a cyber-attack, also experiencing the highest cost of a breach. New ways of seamlessly encrypting data may be the way forward.
The pharmaceutical industry is certainly no stranger to cyber-attacks. Merck & Co., Inc.'s 2017 'NotPetya' cyberattack is still looming large over the industry, as the legal ramifications - including Merck's $1.4bn insurance claim – continue into 2023. (Also see "Merck Cyberattack Recovery: Congress Scrutinizes Manufacturing Problems" - Pink Sheet, 21 September, 2017.)
More recently, AstraZeneca PLC is in the spotlight for a data breach which saw credentials for one of its...
An interactive look at pharma, medtech and diagnostics deals made during May 2025. Data courtesy of Biomedtracker.
Flagship Pioneering senior partner Raj Panjabi discusses shifting health care from reactive treatment to AI-powered prediction and prevention of disease before symptoms emerge.
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.
